Page last updated: 2024-08-26

fulvestrant and wedelolactone

fulvestrant has been researched along with wedelolactone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benes, P; Brezovsky, J; Daniel, L; Nehybova, T; Smarda, J	1

Other Studies

1 other study(ies) available for fulvestrant and wedelolactone

Article	Year
Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling. The Journal of steroid biochemistry and molecular biology, 2015, Volume: 152 Topics: Antineoplastic Agents; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coumarins; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; HEK293 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Response Elements; Signal Transduction; Transcription Factor AP-1; Transcriptional Activation	2015

Article

Year

Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling.

The Journal of steroid biochemistry and molecular biology, 2015, Volume: 152

Topics: Antineoplastic Agents; Binding Sites; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coumarins; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Estrogen Receptor beta; Estrogens; Female; Fulvestrant; HEK293 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Response Elements; Signal Transduction; Transcription Factor AP-1; Transcriptional Activation

2015